 |
Amazon
LUNG SUPPORT*
120 capsules (600 mg each)
Buy Now
|
|
A botanical formula which combines 7 plants traditionally used in South America for the lungs and respiratory system.* For more information on the individual ingredients in Amazon Lung Support, follow the links provided below to the plant database files in the Tropical Plant Database.
Each rainforest botanical in this professional formula has been sustainably harvested in the Amazon Rainforest. Click here to learn more about our rainforest ingredients and wild harvesting methods. This product contains no binders, fillers, or exipients and is 100% finely milled natural plants. This product is backed by Raintree's Unconditional Guarantee.
Ingredients: A proprietary blend of amor seco, embauba, avenca, mullaca, jatoba, mutamba, and samambaia. This formula is 100% pure natural ground plants. No binders, fillers or other additives are used. These plants have grown naturally in the richness of the Amazon without any pesticides or fertilizers and they are non-irradiated and non-fumigated.
Suggested Use: Take 2 capsules 2-3 times daily.
Contraindications:
- Not to be used during pregnancy or while breast-feeding.
- This formula should not be used in combination with digitalis.
- Those with cardiac disorders should be monitored more closely when taking this formula.
Drug Interactions: None reported; however, based on animal studies, it may potentiate digitalis, ACE-inhibitor, hypoglycemic, and hypotensive drugs.
Other Practitioner Observations:
- Several plants in this formula have been documented to reduce blood pressure in animal studies. Individuals with low blood pressure should be monitored for this possible effect.
- Several ingredients have shown a hypoglycemic effect in animal studies. Those with hypoglycemia should monitor their blood sugar levels for this possible effect.
A 120 capsule bottle is $29.95 each
Or buy 3 bottles for $28.95 each
Or buy 6 bottles for $26.95 each
Buy Now
Print a PDF Amazon Lung Support Brochure
Please note that this is a professional product offered by health practitioners and it is not available in retail stores. Click here to see a list of practitioners who use our products.
|
|
Third-Party Published Research*
This proprietary Raintree product has not been the subject of any clinical research. A partial listing of third-party published research on each herbal ingredient in the formula is shown below. Please refer to the plant database files by clicking on the plant names below to see all available documentation and research on each plant ingredient.
Amor Seco (Desmodium adscendens)
Barreto, G. S. “Effect of butanolic fraction of Desmodium adscendens on the anococcygeus of the rat.” Braz. J.
Biol. 2002; 62(2): 223–30.
Addy, M. E., et al. “Dose-response effects of Desmodium adscendens aqueous extract on histamine response,
content and anaphylactic reactions in the guinea pig.” J. Ethnopharmacol. 1996; 18(1): 13–20.
Addy, M. E., et al. “An extract of Desmodium adscendens activates cyclooxygenase and increases
prostaglandin synthesis by ram seminal vesicle microsomes.” Phytother. Res. 1995; 9(4): 287–93.
McManus, O. B., et al. “An activator of calcium-dependent potassium channels isolated from a medicinal herb.”
Biochemistry 1993; 32(24): 6128–33.
Addy, M. E., et al. “Some secondary plant metabolites in Desmodium adscendens and their effects on
arachidonic acid metabolism.” Prostaglandins Leukotrienes Essent. Fatty Acids 1992; 47(1): 85–91.
Boye, G. and O. Ampopo. “Plants and traditional medicine in Ghana.” Economic and Medicinal Plant Research
4 1990. Devon, England: Academic Press Ltd.: 33–4.
Addy, M. E., et al. “Effect of Desmodium adscendens fraction 3 on contractions of respiratory smooth muscle.”
J. Ethnopharmacol. 1990; 29(3): 325–35.
Addy, M. E., et al. “Effect of Desmodium adscendens fraction F1 (DAFL) on tone and agonist-induced
contractions of guinea pig airway smooth muscle.” Phytother. Res. 1989; 3(3): 85–90.
Addy, M. E., et al. “Several chromatographically distinct fractions of Desmodium adscendens inhibit smooth
muscle contractions.” Int. J. Crude Drug Res. 1989; 27(2): 81–91.
Addy, M. E., et al. “Effect of Desmodium adscendens fractions on antigen- and arachidonic acid-induced
contractions of guinea pig airways.” Can. J. Physiol. Pharmacol. 1987; 66(6): 820–25.
Addy, M. E., et al. “Dose-response effect of one subfraction of Desmodium adscendens aqueous extract on
antigen- and arachidonic acid-induced contractions of guinea pig airways.” Phytother. Res. 1987; 1(4): 180–86.
Addy, M. E., et al. “Effects of the extracts of Desmodium adscendens on anaphylaxis.” J. Ethnopharmacol.
1984; 11(3): 283–92.
Embauba (Cecropia peltata)
Carbajal, D., et al. “Pharmacological screening of plant decoctions commonly used in Cuban folk medicine.” J.
Ethnopharmacol. 1991; 33: 21–4.
Perea Guerrero, C., et al. “A pharmacological study of Cecropia obtusifolia Bertol. aqueous extract.” J.
Ethnopharmacol. 2001; 76(3): 279–84.
Feng, P. C., et al. “Pharmacological screening of some West Indian medicinal plants.” J. Pharm. Pharmacol.
1962; 14: 556–61.
Velazquez, E., et al. “Antioxidant activity of Paraguayan plant extracts.” Fitoterapia. 2003; 74(1–2): 91–7.
Avenca (Adiantum capillus-veneris)
Mahmoud, M. J., et al. “In vitro antimicrobial activity of Salsola rosmarinus and Adiantum capillus-veneris.” Int.
J. Crude Drug Res. 1989; 27(1): 14–16.
Husson, G. P., et al. “Research into antiviral properties of a few natural extracts.” Ann. Pharm. Fr. 1986; 44(1):
41–8.
Mullaca (Physalis angulata)
Silva, M. T., et al. “Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and
physalin B bringing out the importance of assay determination.” Mem. Inst. Oswaldo Cruz. 2005 Nov; 100(7):
779-82.
Bastos, G. N., et al. “Antinociceptive effect of the aqueous extract obtained from roots of Physalis angulata L.
on mice.” J. Ethnopharmacol. 2006 Jan; 103(2): 241-5.
Vieira, A.T., et al. “Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model
of intestinal ischaemia and reperfusion injury.” Br. J. Pharmacol. 2005 Sep; 146(2): 244-51.
Choi, E. M., et al. “Investigations of anti-inflammatory and antinociceptive activities of Piper cubeba, Physalis
angulata and Rosa hybrida.” J. Ethnopharmacol. 2003 Nov; 89(1): 171-5.
Cox, P. A. “Pharmacological activity of the Samoan ethnopharmacopoeia.” Econ. Bot. 1989; 43(4): 487–97.
Pietro, R. C., et al. “In vitro antimycobacterial activities of Physalis angulata L.” Phytomedicine 2000; 7(4):
335–38.
Januario, A. H., et al. “Antimycobacterial physalins from Physalis angulata L. (Solanaceae).” Phytother. Res.
2002; 16(5): 445-48.
Hussain, H., et al. “Plants in Kano ethnomedicine; screening for antimicrobial activity and alkaloids.” Int. J.
Pharmacol. 1991; 29(1): 51–56.
Jatoba (Hymenaea courbaril)
Abdel-Kader, M., et al. “Isolation and absolute configuration of ent-Halimane diterpenoids from Hymenaea
courbaril from the Suriname rain forest.” J. Nat. Prod. 2002; 65(1): 11-5.
Rahalison, L., et al. “Screening for antifungal activity of Panamanian plants.” Inst. J. Pharmacog. 1993; 31(1):
68–76.
Verpoorte, R., et al. “Medicinal plants of Surinam. IV. Antimicrobial activity of some medicinal plants.” J.
Ethnopharmacol. 1987; 21(3): 315–18.
Arrhenius, S.P., et al. “Inhibitory effects of Hymenaea and Copaifera leaf resins on the leaf fungus, Pestalotia
subcuticulari.” Biochem. Syst. Ecol. 1983; 11(4): 361–66.
Giral, F., et al. “Ethnopharmacognostic observation on Panamanian medicinal plants. Part 1.” Q. J. Crude Drug
Res. 1979; 167(3/4): 115–30.
Mutamba (Guazuma ulmifolia)
Caceres, A., et al. “Plants used in Guatemala for the treatment of respiratory diseases. 2: Evaluation of activity
of 16 plants against gram-positive bacteria.” J. Ethnopharmacol. 1993; 39(1): 77–82.
Camporese, A., et al. “Screening of anti-bacterial activity of medicinal plants from Belize (Central America).” J.
Ethnopharmacol. 2003 Jul; 87(1): 103-7.
Navarro, M. C., et al. “Antibacterial, antiprotozoal and antioxidant activity of five plants used in Izabal for
infectious diseases.” Phytother. Res. 2003; 17(4): 325-9.
Caceres, A., et al. “Plants used in Guatemala for the treatment of gastrointestinal disorders. 3. Confirmation of
activity against enterobacteria of 16 plants.” J. Ethnopharmacol. 1993; 38(1): 31–38.
Samambaia (Polypodium decumanum)
Punzon, C., et al. “In vitro anti-inflammatory activity of Phlebodium decumanum. Modulation of tumor necrosis
factor and soluble TNF receptors.” Int. Immunopharmacol. 2003; 3(9): 1293-9.
Manna, S. K., et al. ”Calagualine inhibits nuclear transcription factors-kappaB activated by various
inflammatory and tumor promoting agents.” Cancer Lett. 2003; 190(2): 171-82.
Navarro-Blasco, F. J., et al. “Modification of the inflammatory activity of psoriatic arthritis in patients treated with
extract of Polypodium leucotomos (Anapsos).” Br. J. Rheumatol. 1998; 37(8): 912.
Reyes, E., et al. “Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA
therapy in generalized vitiligo: A pilot study.” J. Dermatol. Sci. 2006 Jan 16;
Nogal-Ruiz, J. J., “Modulation by Polypodium leucotomos extract of cytokine patterns in experimental
trichomoniasis model.” Parasite. 2003 Mar; 10(1): 73-8.
Sempere-Ortells, J. M., et al. “Anapsos (Polypodium leucotomos) modulates lymphoid cells and the expression
of adhesion molecules.” Pharmacol. Res. 2002; 46(2): 185–90.
Gonzalez, S., et al. “An extract of the fern Polypodium leucotomos (Difur) modulates Th1/Th2 cytokines
balance in vitro and appears to exhibit anti-angiogenic activities in vivo: Pathogenic relationships and
therapeutic implications.” Anticancer Res. 2000; 20(3a): 1567–75.
Sempere-Ortells , J. M., et al. “Effect of Anapsos (Polypodium leucotomos extract) on in vitro production of
cytokines.” Br. J. Clin. Pharmacol. 1997; 43(1): 85–9.
Bernd, A., et al. “In vitro studies on the immunomodulating effects of Polypodium leucotomos extract on human
leukocyte fractions.” Arzneimittelforschung. 1995; 45(8): 901–4.
|
* The statements contained herein have not been evaluated
by the Food and Drug Administration.
This product is
not intended to treat, cure, mitigate or prevent any disease.
Please refer to our Conditions of Use for this web site and product.
Thank you for your support and
for choosing a Raintree product!
Raintree Nutrition, Inc.
3579 Hwy 50 East, Suite 222
Carson City, NV 89701
(800) 780-5902
(775) 841-4142
(775) 841-4022 Fax
Return to Main Product Page
    
© Copyrighted 1996
to present by Raintree Nutrition, Inc., Carson City, NV 89701. All rights reserved.
Please read the Conditions of Use, Copyright Statement and our Privacy Policy for this web page and web site.
Updated 12-31-06
|